1.
Scand J Urol
; 52(1): 1-7, 2018 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28818014
RESUMO
The impact of cytoreductive radical prostatectomy on oncological outcome in patients with prostate cancer and limited number of bone metastases is unclear. Data from cancer registries, multi-institutional databases and a single institutional case-control study indicate a possible benefit of combined cytoreduction and hormonal therapy compared to hormonal therapy alone. However, the results may be biased by a number of factors. The evidence from studies on cytoreductive prostatectomy is reviewed.